Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:21623382  

Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome.

Madeline A Lancaster | Dipika J Gopal | Joon Kim | Sahar N Saleem | Jennifer L Silhavy | Carrie M Louie | Bryan E Thacker | Yuko Williams | Maha S Zaki | Joseph G Gleeson
Nature medicine | 2011

The ciliopathy Joubert syndrome is marked by cerebellar vermis hypoplasia, a phenotype for which the pathogenic mechanism is unclear. To investigate Joubert syndrome pathogenesis, we have examined mice with mutated Ahi1, the first identified Joubert syndrome-associated gene. These mice show cerebellar hypoplasia with a vermis-midline fusion defect early in development. This defect is concomitant with expansion of the roof plate and is also evident in a mouse mutant for another Joubert syndrome-associated gene, Cep290. Furthermore, fetal magnetic resonance imaging (MRI) of human subjects with Joubert syndrome reveals a similar midline cleft, suggesting parallel pathogenic mechanisms. Previous evidence has suggested a role for Jouberin (Jbn), the protein encoded by Ahi1, in canonical Wnt signaling. Consistent with this, we found decreased Wnt reporter activity at the site of hemisphere fusion in the developing cerebellum of Ahi1-mutant mice. This decrease was accompanied by reduced proliferation at the site of fusion. Finally, treatment with lithium, a Wnt pathway agonist, partially rescued this phenotype. Our findings implicate a defect in Wnt signaling in the cerebellar midline phenotype seen in Joubert syndrome that can be overcome with Wnt stimulation.

Pubmed ID: 21623382

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: P30NS047101
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS047101-06A1S1
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS048453-08
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS048453
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM08666
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS047101-06A1
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS052455-06
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS052455
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM008666
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS047101-09
  • Agency: NINDS NIH HHS, United States
    Id: R01NS052455
  • Agency: NINDS NIH HHS, United States
    Id: R01NS048453
  • Agency: NINDS NIH HHS, United States
    Id: P30 NS047101

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Covance (tool)

RRID:SCR_001224

A contract research organization providing drug development and animal testing services. Under the name Covance Research Products Inc., based in Denver, Pennsylvania, the company also deals in the import, breeding and sale of laboratory animals. It breeds dogs, rabbits, guinea pigs, non-human primates, and pigs, and runs the largest non-human primate laboratory in Germany. (Wikipedia)

View all literature mentions